GMiA becomes Generic and Biosimilar Medicines Association

From today, the Generic Medicines Industry Association will be known as the Generic and Biosimilar Medicines Association. After patents expire on brand name medicines, affordable generic and biosimilar medicines deliver the same health benefits to patients while also providing savings to taxpayers and the government, GBMA says. This means more patients can have access to